Literature DB >> 17854827

Structural and kinetic properties of lumazine synthase isoenzymes in the order Rhizobiales.

Sebastián Klinke1, Vanesa Zylberman, Hernán R Bonomi, Ilka Haase, Beatriz G Guimarães, Bradford C Braden, Adelbert Bacher, Markus Fischer, Fernando A Goldbaum.   

Abstract

6,7-Dimethyl-8-ribityllumazine synthase (lumazine synthase; LS) catalyzes the penultimate step in the biosynthesis of riboflavin in plants and microorganisms. This protein is known to exhibit different quaternary assemblies between species, existing as free pentamers, decamers (dimers of pentamers) and icosahedrally arranged dodecamers of pentamers. A phylogenetic analysis on eubacterial, fungal and plant LSs allowed us to classify them into two categories: Type I LSs (pentameric or icosahedral) and Type II LSs (decameric). The Rhizobiales represent an order of alpha-proteobacteria that includes, among others, the genera Mesorhizobium, Agrobacterium and Brucella. Here, we present structural and kinetic studies on several LSs from Rhizobiales. Interestingly, Mesorhizobium and Brucella encode both a Type-I LS and a Type-II LS called RibH1 and RibH2, respectively. We show that Type II LSs appear to be almost inactive, whereas Type I LSs present a highly variable catalytic activity according to the genus. Additionally, we have solved four RibH1/RibH2 crystallographic structures from the genera Mesorhizobium and Brucella. The relationship between the active-site architecture and catalytic properties in these isoenzymes is discussed, and a model that describes the enzymatic behavior is proposed. Furthermore, sequence alignment studies allowed us to extend our results to the genus Agrobacterium. Our results suggest that the selective pressure controlling the riboflavin pathway favored the evolution of catalysts with low reaction rates, since the excess of flavins in the intracellular pool in Rhizobiales could act as a negative factor when these bacteria are exposed to oxidative or nitrosative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854827     DOI: 10.1016/j.jmb.2007.08.021

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Crystallographic and kinetic study of riboflavin synthase from Brucella abortus, a chemotherapeutic target with an enhanced intrinsic flexibility.

Authors:  María I Serer; Hernán R Bonomi; Beatriz G Guimarães; Rolando C Rossi; Fernando A Goldbaum; Sebastián Klinke
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-04-30

Review 2.  Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers.

Authors:  Charles A Abbas; Andriy A Sibirny
Journal:  Microbiol Mol Biol Rev       Date:  2011-06       Impact factor: 11.056

3.  Proteomics-based confirmation of protein expression and correction of annotation errors in the Brucella abortus genome.

Authors:  Julie Lamontagne; Maxime Béland; Anik Forest; Alexandra Côté-Martin; Najib Nassif; Fadi Tomaki; Ignacio Moriyón; Edgardo Moreno; Eustache Paramithiotis
Journal:  BMC Genomics       Date:  2010-05-12       Impact factor: 3.969

4.  Unusual arginine formations in protein function and assembly: rings, strings, and stacks.

Authors:  Marco A C Neves; Mark Yeager; Ruben Abagyan
Journal:  J Phys Chem B       Date:  2012-04-19       Impact factor: 2.991

5.  An atypical riboflavin pathway is essential for Brucella abortus virulence.

Authors:  Hernán Ruy Bonomi; María Inés Marchesini; Sebastián Klinke; Juan E Ugalde; Vanesa Zylberman; Rodolfo A Ugalde; Diego J Comerci; Fernando Alberto Goldbaum
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

6.  Asymmetric bifunctional protein nanoparticles through redesign of self-assembly.

Authors:  Santiago Sosa; Andrés H Rossi; Alan M Szalai; Sebastián Klinke; Jimena Rinaldi; Ana Farias; Paula M Berguer; Alejandro D Nadra; Fernando D Stefani; Fernando A Goldbaum; Hernán R Bonomi
Journal:  Nanoscale Adv       Date:  2019-02-21

7.  Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.

Authors:  Daniel Ellis; Natalie Brunette; Katharine H D Crawford; Alexandra C Walls; Minh N Pham; Chengbo Chen; Karla-Luise Herpoldt; Brooke Fiala; Michael Murphy; Deleah Pettie; John C Kraft; Keara D Malone; Mary Jane Navarro; Cassandra Ogohara; Elizabeth Kepl; Rashmi Ravichandran; Claire Sydeman; Maggie Ahlrichs; Max Johnson; Alyssa Blackstone; Lauren Carter; Tyler N Starr; Allison J Greaney; Kelly K Lee; David Veesler; Jesse D Bloom; Neil P King
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.